flag flag  

Highly active antiretroviral therapy started in infants under 3 months of age: 72-week follow-up for CD4 cell count, viral load and drug resistance outcome

Description : Objective: To assess the feasibility and impact of highly active antiretroviral therapy (HAART) started in vertically HIV-1-infected infants less than 3 months of age.Design: A multicentre, phase I/II, non-randomized, open-label study (PENTA 7).Methods: Adverse events, plasma HIV-1 RNA, CD4 cell cou...
Language(s) : Undetermined
Subject(s) : highly active antiretroviral therapy, infants, CD4 cell count, viral load, drug resistance, IMMUNODEFICIENCY-VIRUS TYPE-1, HIV-1 INFECTION, 1-INFECTED INFANTS, PROTEASE INHIBITOR, CHILDREN, NELFINAVIR, MORTALITY, PHARMACOKINETICS, REPLICATION, RESPONSES
Publisher(s) : LIPPINCOTT WILLIAMS & WILKINS
Contributor(s) :
Source(s) :
Publication Date(s) : 2004-01-23